Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Environmental Health Perspectives|July 20, 2007
Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivorsRegina Rückerl, Sonja Greven, Petter Ljungman, et al.
Journal of the Air & Waste Management Association (1995)|September 29, 2005
Aerosol particle number concentration measurements in five European cities using TSI-3022 condensation particle counter over a three-year period during health effects of air pollution on susceptible subpopulationsPasi Aalto, Kaarle Hämeri, Pentti Paatero, et al.
Pharmacoepidemiology and Drug Safety|August 26, 2015
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approachFredrik Nyberg, Johan Askling, Niklas Berglind, et al.
Arthritis Care & Research|July 24, 2015
Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational RegistriesSuzanne M M Verstappen, Johan Askling, Niklas Berglind, et al.
Annals of the Rheumatic Diseases|December 2, 2015
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registriesJohan Askling, Niklas Berglind, Stefan Franzen, et al.
Annals of the Rheumatic Diseases|February 10, 2016
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular diseaseKaleb Michaud, Niklas Berglind, Stefan Franzén, et al.
RMD Open|October 31, 2017
Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programmeHisashi Yamanaka, Johan Askling, Niklas Berglind, et al.
British Journal of Clinical Pharmacology|December 9, 2025
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory studyJuan Carlos Garcia-Pagan, Lise Lotte Gluud, Mattias Mandorfer, et al.
Pageof 3